NO156516C - Fremgangsmaate for fremstilling av modulatorer for immunsystemet. - Google Patents
Fremgangsmaate for fremstilling av modulatorer for immunsystemet.Info
- Publication number
- NO156516C NO156516C NO811626A NO811626A NO156516C NO 156516 C NO156516 C NO 156516C NO 811626 A NO811626 A NO 811626A NO 811626 A NO811626 A NO 811626A NO 156516 C NO156516 C NO 156516C
- Authority
- NO
- Norway
- Prior art keywords
- modulators
- effects
- suppressor
- human
- immunity system
- Prior art date
Links
- 210000000987 immune system Anatomy 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 7
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000036039 immunity Effects 0.000 abstract 2
- 230000004044 response Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 208000006313 Delayed Hypersensitivity Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010040914 Skin reaction Diseases 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 241000159243 Toxicodendron radicans Species 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000000385 dialysis solution Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000009290 primary effect Effects 0.000 abstract 1
- 230000035483 skin reaction Effects 0.000 abstract 1
- 231100000430 skin reaction Toxicity 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14973780A | 1980-05-14 | 1980-05-14 | |
| US25688681A | 1981-05-06 | 1981-05-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO811626L NO811626L (no) | 1981-11-16 |
| NO156516B NO156516B (no) | 1987-06-29 |
| NO156516C true NO156516C (no) | 1987-10-07 |
Family
ID=26846987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO811626A NO156516C (no) | 1980-05-14 | 1981-05-13 | Fremgangsmaate for fremstilling av modulatorer for immunsystemet. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0042064B1 (no) |
| JP (1) | JPH0453848B2 (no) |
| AU (1) | AU555652B2 (no) |
| CA (1) | CA1163194A (no) |
| DE (1) | DE3176443D1 (no) |
| DK (1) | DK214481A (no) |
| FI (1) | FI78483C (no) |
| IE (1) | IE53572B1 (no) |
| IL (1) | IL62870A (no) |
| NO (1) | NO156516C (no) |
| WO (1) | WO1981003279A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468379A (en) * | 1982-05-06 | 1984-08-28 | Endeavor Corp. | Leukocyte extracts for affecting the immune system |
| US4616079A (en) * | 1984-08-24 | 1986-10-07 | Imreg, Inc. | Immunoamplifiers and processes for the extraction thereof |
| CA1286989C (en) * | 1985-12-26 | 1991-07-30 | A. Arthur Gottlieb | Immunoamplifiers and related compositions |
| EP0247538A3 (en) * | 1986-05-28 | 1989-08-30 | Imreg, Inc. | Immunosuppressor and method of extraction thereof |
| GB8614733D0 (en) * | 1986-06-17 | 1986-07-23 | Lefesvre A | Aids treatment |
| ATE158184T1 (de) * | 1990-07-02 | 1997-10-15 | Nat Jewish Ct Immun & Respirat | Herstellung und verwendung von transfer-faktor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991182A (en) * | 1971-10-19 | 1976-11-09 | The Regents Of The University Of California | Transfer factor |
| US4132776A (en) * | 1978-02-15 | 1979-01-02 | University Patents, Inc. | Delivery of immunologically active components of transfer factor |
| US4180627A (en) * | 1978-08-17 | 1979-12-25 | The United States Of America As Represented By The Secretary Of Agriculture | Process for in vivo transfer of cell-mediated immunity in mammals with alcoholic precipitates of Bovine Transfer factor |
| WO1980000790A1 (en) * | 1978-10-25 | 1980-05-01 | Benzon As Alfred | Transfer factor and method for producing same |
-
1981
- 1981-05-13 FI FI811473A patent/FI78483C/fi not_active IP Right Cessation
- 1981-05-13 NO NO811626A patent/NO156516C/no unknown
- 1981-05-13 IE IE1075/81A patent/IE53572B1/en not_active IP Right Cessation
- 1981-05-14 WO PCT/US1981/000640 patent/WO1981003279A1/en unknown
- 1981-05-14 AU AU70578/81A patent/AU555652B2/en not_active Ceased
- 1981-05-14 EP EP81103702A patent/EP0042064B1/en not_active Expired
- 1981-05-14 JP JP56501991A patent/JPH0453848B2/ja not_active Expired - Lifetime
- 1981-05-14 DE DE8181103702T patent/DE3176443D1/de not_active Expired
- 1981-05-14 IL IL62870A patent/IL62870A/xx unknown
- 1981-05-14 DK DK214481A patent/DK214481A/da not_active Application Discontinuation
- 1981-05-14 CA CA000377601A patent/CA1163194A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1163194A (en) | 1984-03-06 |
| EP0042064A3 (en) | 1983-01-19 |
| AU555652B2 (en) | 1986-10-02 |
| IE53572B1 (en) | 1988-12-21 |
| DK214481A (da) | 1981-11-15 |
| DE3176443D1 (en) | 1987-10-22 |
| AU7057881A (en) | 1981-11-19 |
| WO1981003279A1 (en) | 1981-11-26 |
| IL62870A (en) | 1985-03-31 |
| EP0042064A2 (en) | 1981-12-23 |
| NO156516B (no) | 1987-06-29 |
| JPH0453848B2 (no) | 1992-08-27 |
| IE811075L (en) | 1981-11-14 |
| FI78483C (fi) | 1989-08-10 |
| FI811473L (fi) | 1981-11-15 |
| NO811626L (no) | 1981-11-16 |
| EP0042064B1 (en) | 1987-09-16 |
| IL62870A0 (en) | 1981-07-31 |
| FI78483B (fi) | 1989-04-28 |
| JPS57500611A (no) | 1982-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3375759D1 (en) | Process for purifying modulators of the immune system | |
| NO156553C (no) | Fremgangsmaate for fremstilling av en vandig farmasoeytisk opploesning inneholdende ubidecarenon. | |
| NO821676L (no) | Fremgangsmaate for fremstilling av et anti-virusaktivt guaninderivat. | |
| GB2079179B (en) | Cosmetic composition based on an aqueous dispersion of small lipid spheres | |
| AU8107682A (en) | Quinoline carboxamides and their derivatives | |
| NO883964L (no) | Fremgangsmaate for fremstilling av et antioksydant-ekstrakt fra krydder. | |
| ATE67683T1 (de) | Vorrichtung mit verzoegerter wirkung. | |
| NL190311C (nl) | Cosmetisch preparaat voor de behandeling van keratine bevattende materialen. | |
| IT8322141A0 (it) | Procedimento di occultazione delle radiazioni visibile e infrarossa e munizione fumogena di attuazione di tale procedimento. | |
| Ravizza et al. | Hearing in primitive mammals: I. Opossum (Didelphis virginianus). | |
| NL190399B (nl) | Ijzer-bevattend eiwitmateriaal, bereiding daarvan, en farmaceutisch preparaat voor de behandeling van sideropene anaemie. | |
| NO156516C (no) | Fremgangsmaate for fremstilling av modulatorer for immunsystemet. | |
| NL7904059A (nl) | Preparaat voor het reduceren van technetium, werkwijze voor de bereiding daarvan, en toepassingen daarvan. | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| NL7610602A (nl) | Werkwijze voor de bereiding van rodenticidepre- paraten en werkwijze voor de bereiding van de werkzame bestanddelen daarvan. | |
| NL7612200A (nl) | Retinezuurderivaat alsmede farmaceutisch preparaat voor de behandeling van acne. | |
| NL182445B (nl) | Zure, waterige, eetbare dispersie en werkwijze voor de bereiding daarvan. | |
| CS189028B2 (en) | Fundicide and bactericide preparations for the suppression of maladies and method of preparation the active substances | |
| ZA792939B (en) | Membrane stabilizing compounds having b-receptor blocking activity,their preparation,method for treatment of arrhythmic conditions,and pharmaceutical preparations containing same | |
| DE3268160D1 (en) | Medicaments based on algae, and formulations thereof | |
| NL7610058A (nl) | Werkwijze voor de bereiding van diervoerpre- paraten. | |
| NL7901941A (nl) | Tegengif voor behandeling van dieren en pluimvee tegen acute vergiftiging door fosfororganische bestrijdings- middelen. | |
| NO140988C (no) | Fremgangsmaate for fremstilling av agglomerater av silisium- eller silisiumlegeringspartikler | |
| NL7902450A (nl) | Farmaceutisch preparaat met anti-complementaire wer- king, werkwijze voor de bereiding daarvan alsmede werk- wijze voor het behandelen van nephritis. | |
| SE8303729L (sv) | Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer |